Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone

Gynecological Endocrinology

Volumn 14, Issue 3, 2000, Pages 173-181

  Seippel, L ^a   Eriksson, O ^b   Grankvist, K ^a   Von Shoultz, B ^c   Backstrom T ^a,d  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Desoxycorticosterone; Mineralocorticoids; Premenstrual syndrome; Progesterone

Indexed keywords

3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; DEOXYCORTICOSTERONE; MINERALOCORTICOID; PROGESTERONE;

ADULT; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; FEMALE; FLUID BALANCE; HUMAN; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SYMPTOM;

EID: 0033918432     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167679     Document Type: Article

References (35)

1. 1. Wood SH, Mortola JF, Chan YF, et al. Treatment of premenstrual syndrome with fluoxctine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol 1992;80:339-44
2. 2. Sundström I, Bäckström T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 1998;23:73-88
3. 3. Bancroft J, Bäckström T. Premenstrual syndrome. Clin Endocrinol 1985;22:313-36
4. 4. Halbreich U, Endicott J, Lesser J. The clinical diagnosis and classification of premenstrual changes. Can J Psychiatry 1985;30:489-97
5. 5. Korzekwa MI, Steiner M. Premenstrual syndromes. Clin Obstet Gynecol 1997;40:564-76
6. 6. Janowsky DS, Berens DC, Davis JM. Correlations between mood, weight and electrolytes during the menstrual cycle: a renin-angiotensin-aldosterone hypothesis of premenstrual tension. Psychosom Med 1973;35:143-54
7. 7. Munday M, Brush MG, Taylor RW. Correlations between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome, Clin Endocrinol 1981;14:1-9
8. 8. Andersch B, Hahn L, Andersson M, et al. Body water and weight in patients with premenstrual tension. Br J Obstet Gynaecol 1978;85:546-50
9. 9. Davidson BJ, Rea CD, Valenzuela GJ. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Fertil Steril 1988;50:743-6
10. 10. Cerin Å, Collins A, Landgren B-M, et al. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. Acta Obstet Gynecol Scand 1993;72:337-43
11. 11. Burton G, Galigniana M, De Lavallaz S, et al. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids. Mol Pharmacol 1995;47:535-43
12. 12. Parker CR, Winkel CA, Rush AJ, et al. Plasma concentrations of 11-desoxycorticosterone in women during the menstrual cycle. Obstet Gynecol 1981;58:26-30
13. 13. Antonipillai I, Moghissi E, Hawks D, et al. The origin of plasma desoxycorticosterone in men and in women during the menstrual cycle. J Clin Endocrinol Metab 1983;56:93-8
14. 14. Winkel CA, Parker CR, Simpson ER, et al. Production rate of desoxycorticosterone in women during the follicular and luteal phases of the ovarian cycle: the role of extraadrenal 21-hydroxylation of circulating progesterone in desoxycorticosterone production. J Clin Endocrinol Metab 1980;51:1354-8
15. 15. Kraulis I, Foldes G, Traikov H, et al. Distribution, metabolism and biological activity of deoxycorticosterone in the central nervous system. Brain Res 1975;88:1-14
16. 16. Teschemacher A, Zeise ML, Holsboer F, et al. The neuroactive steroid 5 alpha-tetrahydrodeoxycorticosterone increases GABAergic postsynaptic inhibition in rat neocortical neurons in vitro. J Neuroendocrinol 1995;7:233-40
17. 17. Wieland S, Lan NC, Mirasedeghi S, et al. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Brain Res 1991;565:263-8
18. 18. Rodgers RJ, Johnson NJ. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav 1998;59:221-32
19. 19. Wang M, Seippel L, Purdy RH, et al. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 1996;81:1076-82
20. 20. Sundström I, Andersson A, Nyberg S, et al. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998;67:126-38
21. 21. American Psychiatric Association. Premenstrual dysphoric disorder. In Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994: 714-18
22. 22. Hammarbäck S, Bäckström T, MacGibbon-Taylor B. Diagnosis of premenstrual syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Gynaecol 1989;10:25-42
23. 23. Bäckström T, Carlström K, von Schoultz B, et al. Effect of progesterone, administered via intravaginal rings, on serum concentrations of oestradiol, FSH, LH and prolactin in women. J Reprod Fertil 1982;64:53-8
24. 24. Manlimos FS, Maroulis GB, Abraham GE. Radioimmunoassay of plasma 11-desoxycorticosterone. Anal Lett 1975;8:931-8
25. 25. Brenner PF, Guerrero R, Cekan Z, et al. Radioimmunoassay method for six steroids in human plasma. Steroids 1973;22:775-94
26. 26. Aitken RCB. Measurements of feelings using visual scale. Proc R Soc Med 1969;62:989-93
27. 27. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psychophysiological classroom experiment. Br J Clin Pharmacol 1978;6:15-21
28. 28. Callahan LF, Pinctus T. A clue from self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. The P-VAS : D-ADL ratio. Arthritis Rheum 1990;33:1317-22
29. 29. Jorgensen J, Rossignol AM, Bonnlander H. Evidence against multiple premenstrual syndromes: results of a multivariate profile analysis of premenstrual symptomatology. J Psychosom Res 1993;37:257-63
30. 30. Hammarbäck S, Bäckström T, Holst J, et al. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985;64:393-7
31. 31. Wang M, Hammarbäck S, Lindhe BA, et al. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet Gynecol Scand 1995;74:803-8
32. 32. Ekholm UB, Hammarbäck S, Bäckström T. Premenstrual syndrome: changes in symptom pattern between two menstrual cycles. J Psychosom Obstet Gynecol 1992;13:107-19
33. 33. MacGregor EA, Chia H, Vohrah RC, Wilkinson M. Migraine and menstruation: a pilot study. Cephatalgia 1990;10:305-10
34. 34. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976;54:321-47
35. 35. Ottoson U-B, Carlström K, Damber J-E, et al. Serum levels of progesterone and some of its metabolites including desoxycorticosterone after oral and parenteral administration. Br J Obstet Gynaecol 1984;91:1111-19